Advanced in HIV/AIDS

Mookho Malahleha

East London, EC, ZA 
Advanced in HIV/AIDS
East London, EC, ZA 
OverviewLocationsClinical Research

Overview

Mookho Malahleha practices in East London, South Africa. Malahleha is rated as an Advanced expert by MediFind in the treatment of HIV/AIDS. Their top areas of expertise are HIV/AIDS, Pulmonary Tuberculosis, Severe Acute Respiratory Syndrome (SARS), and COVID-19.

Their clinical research consists of co-authoring 31 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 17 articles in the study of HIV/AIDS.

Locations

East London, EC, South Africa
Other Locations
Soshanguve, NW, South Africa
Pretoria, GT, South Africa
University Of Cape Town, Cape Town, South Africa, WC, South Africa
Groote Schuur Hospital And The University Of Cape Town, Cape Town, WC, South Africa
University Of Cape Town, Cape Town, Glaxo, Johannesburg, GT, South Africa

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

An Open-Label, Partially Randomized Trial to Evaluate the Efficacy, Safety and Tolerability of a 4-month Treatment of Bedaquiline Plus Pretomanid Plus Moxifloxacin Plus Pyrazinamide (BPaMZ) Compared to a 6-month Treatment of HRZE/HR (Control) in Adult Participants With Drug-Sensitive Smear-Positive Pulmonary Tuberculosis (DS-TB) and a 6-month Treatment of BPaMZ in Adult Participants With Drug Resistant, Smear-Positive Pulmonary Tuberculosis (DR-TB)
An Open-Label, Partially Randomized Trial to Evaluate the Efficacy, Safety and Tolerability of a 4-month Treatment of Bedaquiline Plus Pretomanid Plus Moxifloxacin Plus Pyrazinamide (BPaMZ) Compared to a 6-month Treatment of HRZE/HR (Control) in Adult Participants With Drug-Sensitive Smear-Positive Pulmonary Tuberculosis (DS-TB) and a 6-month Treatment of BPaMZ in Adult Participants With Drug Resistant, Smear-Positive Pulmonary Tuberculosis (DR-TB)
Enrollment Status: Completed
Publish Date: March 07, 2024
Intervention Type: Drug
Study Drugs: Pretomanid, Bedaquiline, Moxifloxacin, Pyrazinamide, HRZE, HR
Study Phase: Phase 2/Phase 3
Open-label, Single-arm Phase 3B Implementation Study to Monitor the Effectiveness of the Single-dose Ad26.COV2.S COVID-19 Vaccine Among Health Care Workers in South Africa (VAC31518COV3012)
Open-label, Single-arm Phase 3B Implementation Study to Monitor the Effectiveness of the Single-dose Ad26.COV2.S COVID-19 Vaccine Among Health Care Workers in South Africa (VAC31518COV3012)
Enrollment Status: Completed
Publish Date: August 01, 2022
Intervention Type: Biological
Study Drug: Ad26.COV2.S COVID-19 vaccine
Study Phase: Phase 3
View 1 Less Clinical Trial

31 Total Publications

Neutralizing and binding antibodies are a correlate of risk of COVID-19 in the CoVPN 3008 study in people with HIV.
Neutralizing and binding antibodies are a correlate of risk of COVID-19 in the CoVPN 3008 study in people with HIV.
Journal: Nature communications
Published: April 09, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Malahleha's expertise for a condition
ConditionClose
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile